This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (16)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Ghada El-Hajj Fuleihan, MD; Edward M. Brown, MD; Kate Curtis; Merle J. Berger, MD; Barry M. Berger, MD; Ray Gleason, PhD; Meryl S. LeBoff, MD

Arch Intern Med. 1992;152(9):1904-1909.

Abstract
Background.—
Continuous regimens of estrogen-progesterone have recently been favored over sequential regimens because of a lower incidence of withdrawal bleeding. To determine whether the beneficial effects of sequential hormonal therapy on bone metabolism are preserved with the newer continuous regimens, we studied indexes of skeletal metabolism and changes in bone mineral density during a 1-year prospective trial.

Methods.—

Our subjects were randomized to one of three treatment groups: those in group C-2.5 were treated with 0.625 mg of conjugated estrogen with 2.5 mg of micronized medroxyprogesterone acetate daily continuously; group C-5 received 0.625 mg of conjugated estrogen and 5.0 mg of micronized medroxyprogesterone acetate daily continuously; and group S-5 received 0.625 mg of conjugated estrogen on days 1 through 25 and 5 mg of micronized medroxyprogesterone acetate on days 14 through 25.

Results.—
At 1 year, all groups demonstrated a significant decrease in indexes of bone formation turnover, including decrements in alkaline phosphatase levels of 11 % to 30% and in osteocalcin levels of 45% to 60%. Intact parathyroid hormone levels rose 10% to 20%, with a concomitant near-significant decrement in ionized calcium levels at 12 months. In addition, there were significant decrements in the 24-hour urinary calcium-creatinine ratios and hydroxyproline-creatinine ratios of 13% to 28%, measures of bone resorption. Linear regression analyses showed that the subjects with the high bone resorption achieved the greatest increment in bone mineral density in response to hormone therapy.

Conclusion.—

The daily continuous estrogen-progesterone regimens are as efficacious as sequential hormonal therapy in decreasing indexes of bone turnover and stabilizing bone mineral density of the spine and proximal femur.

(Arch Intern Med. 1992;152:1904-1909)

Author Affiliations
From the Endocrine-Hypertension Division (Drs El-Hajj Fuleihan, Brown, Gleason, and LeBoff and Ms Curtis), the Department of Pathology (Dr B. Berger), and the Department of Obstetrics and Gynecology (Dr M. Berger), Brigham and Women's Hospital, Boston, Mass.

Footnotes
Accepted for publication January 24, 1992.

Presented in part at the 12th Annual Meeting of the American Society of Bone and Mineral Research, Atlanta, Ga, August 29, 1990.

Reprint requests to Endocrine-Hypertension Division, Brigham and Women's Hospital, 221 Longwood Ave, Boston, MA 02115 (Dr El-Hajj Fuleihan).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Calcifying Subpopulation of Bovine Aortic Smooth Muscle Cells Is Responsive to 17ß-Estradiol
Balica et al.
Circulation 1997;95:1954-1960.
ABSTRACT | FULL TEXT